Mesoblast Q1 2016 Financial Results September 30

Mesoblast presented financial results for the first quarter ended September 30, 2016. The presentation includes forward-looking statements regarding adult stem cell technology development, regulatory timelines, manufacturing processes, and partnerships with JCR Pharmaceuticals and Lonza. The company discusses capital requirements and business growth expectations in an evolving biotech landscape.